Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DarioHealth Corp
DRIO | US
9.70
USD-0.29
-2.90%
DRIO | US
About DarioHealth Corp
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
06/03/2026
Close
9.70
Open
9.52
High
9.79
Low
9.31
DarioHealth Corp. operates as a digital therapeutics company in the United States Canada the European Union Australia and New Zealand. The company offers Dario Evolve a metabolic solution to address metabolic health needs such as diabetes hypertension and weight management; Dario Move which helps to prevent and treat the most common MSK conditions; Dario Elevate a behavioral health solution that optimizes access to evidence-based care; Dario One a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions including live clinical coaching content automated journeys hardware and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York New York.
View LessDRIO | US
Risk
79.8
Sharpe
-0.31
Luna's Score
34/100
Recommendation
Sell
Luna says (DRIO | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
96.9%1 month
79.8%3 months
87.1%6 months
123.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.45
Debt to equity
0.45
Debt to assets
0.25
Ent. to EBITDA
-0.59
Ent. to rev.
2.02
PEG
-
Other Fundamentals
EBITDA
-57.96M
MarketCap
291.27M
MarketCap(USD)
291.27M
Div. yield
-
Op. margin
-258.85
Erngs. growth
-
Rev. growth
1.70
Ret. on equity
-69.37
Short ratio
15.00
Short perc.
6.60
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.82
Range1M
2.92
Range3M
4.33
Volumes: Market Activity
Rel. volume
0.91
Price X volume
165.57K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.59 | 12.67 | Cheaper |
| Ent. to Revenue | 2.02 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.45 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 87.12 | 59.59 | Riskier |
| Debt to Equity | 0.45 | -14.36 | Expensive |
| Debt to Assets | 0.25 | 0.34 | Cheaper |
| Market Cap | 291.27M | 13.71B | Emerging |
